Mostrar el registro sencillo del ítem
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines : World Health Organization consultations, October 2021—March 2022
| dc.contributor.author | Prudden, Holly J. | |
| dc.contributor.author | Achilles, Sharon L. | |
| dc.contributor.author | Schocken, Celina | |
| dc.contributor.author | Broutet, Nathalie | |
| dc.contributor.author | Canfell, Karen | |
| dc.contributor.author | Akaba, Hiroki | |
| dc.contributor.author | Basu, Partha | |
| dc.contributor.author | Bhatla, Neerja | |
| dc.contributor.author | Chirenje, Z. Mike | |
| dc.contributor.author | Delany-Moretlwe, Sinead | |
| dc.contributor.author | Denny, Lynette | |
| dc.contributor.author | Gamage, Deepa G. | |
| dc.contributor.author | Herrero, Rolando | |
| dc.contributor.author | Hutubessy, Raymond | |
| dc.contributor.author | Villa, Luisa Lina | |
| dc.contributor.author | Murillo, Raul | |
| dc.contributor.author | Schiller, John T. | |
| dc.contributor.author | Stanley, Margaret | |
| dc.contributor.author | Temmerman, Marleen | |
| dc.contributor.author | Zhao, Fanghui | |
| dc.contributor.author | Ogilvie, Gina | |
| dc.contributor.author | Kaslow, David C. | |
| dc.contributor.author | Dull, Peter | |
| dc.contributor.author | Gottlieb, Sami L. | |
| dc.contributor.author | Therapeutic HPV Vaccine PPC Expert Consultation Group | |
| dc.coverage.temporal | 2021-2022 | spa |
| dc.date.accessioned | 2023-03-17T19:27:51Z | |
| dc.date.accessioned | 2023-05-11T17:06:04Z | |
| dc.date.available | 2023-03-17T19:27:51Z | |
| dc.date.available | 2023-05-11T17:06:04Z | |
| dc.date.created | 2022-08-22 | |
| dc.identifier | https://www.sciencedirect.com/science/article/pii/S0264410X22009999?via%3Dihub | spa |
| dc.identifier.issn | 0264-410X / 1873-2518 (Electrónico) | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12032/103836 | |
| dc.format | spa | |
| dc.format.mimetype | application/pdf | spa |
| dc.language.iso | eng | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.title | Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines : World Health Organization consultations, October 2021—March 2022 | spa |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
| Understanding t ... ctober 2021—March 2022.pdf | 1.856Mb | application/pdf | Ver/ |
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc/4.0/